FDA to review Acusphere's Imagify

AuntMinnie.com staff writers
Jun 30, 2008

Ultrasound contrast developer Acusphere said that the U.S. Food and Drug Administration (FDA) has accepted its Imagify new drug application (NDA) for review.

Imagify is an ultrasound contrast agent designed to assess myocardial perfusion, according to the Watertown, MA-based firm.

Related Reading

Acusphere revenues flat for Q1 2008, May 9, 2008

Acusphere submits NDA for Imagify, April 29, 2008

Acusphere cuts annual net loss, March 17, 2008

Acusphere gets Nasdaq warning letter, January 14, 2008

Acusphere reports Q3 results, November 9, 2007

Copyright © 2008 AuntMinnie.com

Latest in Ultrasound
Ultrasound Scanner Ultraviolet 400
Deep-learning algorithm improves liver fibrosis diagnosis
April 23, 2024
Screenshot (1142)
POCUS used widely in lung ultrasound applications
April 17, 2024
Img 2490
UltraCon: Expert talks ultrasound's role in imaging dense breasts
April 12, 2024
Andreas Giannakou, MD, from Brigham & Women’s Hospital and Harvard Medical School presents research highlighting how many women with early-stage HR+HER2- breast cancer and a negative presurgical axillary ultrasound can skip sentinel lymph node biopsy.
Negative axillary ultrasound can lead to breast biopsy omission
April 12, 2024
Related Stories
2008 06 10 13 44 22 20 Rectus Femoris Thumb 2008 06 16
Ultrasound
Case study: Complete rectus femoris tear in an adolescent soccer player
2008 06 09 09 43 38 404 Vasiliev thumb 06 08
Ultrasound
Video game technology speeds beating-heart surgery
2008 03 16 22 13 45 706
Ultrasound
Pictorial essay: 3D ultrasound reveals shoulder pathology
2008 03 11 16 23 42 706
Ultrasound
3D US of uterus a helpful adjunct to 2D scans, study finds
More in Ultrasound
Deep-learning algorithm improves liver fibrosis diagnosis
By Amerigo Allegretto
An algorithm combining the Fibrosis-4 Index and an ultrasound deep-learning model could improve diagnostic accuracy for advanced liver fibrosis.
April 23, 2024
Ultrasound Scanner Ultraviolet 400
POCUS used widely in lung ultrasound applications
By Amerigo Allegretto
Some of the top domains for users of point-of-care ultrasound (POCUS) incorporate the technology for lung ultrasound applications.
April 17, 2024
Screenshot (1142)
UltraCon: Expert talks ultrasound's role in imaging dense breasts
By Amerigo Allegretto
Kibo Nam, PhD, from Thomas Jefferson University spoke with AuntMinnie.com about the current state of ultrasound in imaging dense breasts.
April 12, 2024
Img 2490
Negative axillary ultrasound can lead to breast biopsy omission
By Amerigo Allegretto
Many women with early-stage HR+HER2- breast cancer and a negative presurgical axillary ultrasound can skip sentinel lymph node biopsy.
April 12, 2024
Andreas Giannakou, MD, from Brigham & Women’s Hospital and Harvard Medical School presents research highlighting how many women with early-stage HR+HER2- breast cancer and a negative presurgical axillary ultrasound can skip sentinel lymph node biopsy.
UltraCon: Work-related MSK disorders tied to sonographer burnout
By Amerigo Allegretto
Work-related musculoskeletal (MSK) disorders are tied to work-related burnout among sonographers, according to research highlighted April 10 at UltraCon.
April 11, 2024
Jennifer Bagley from the University of Oklahoma Health Sciences Center presents results at UltraCon suggesting that work-related musculoskeletal disorders are tied to burnout among sonographers.
CEUS adds to locoregional therapy for liver disease
By Amerigo Allegretto
Contrast-enhanced ultrasound (CEUS) can improve locoregional therapy for treating metastatic disease of the liver.
April 11, 2024
Corinne Wessner from Thomas Jefferson University discusses early study results at UltraCon showing the potential of ultrasound-triggered microbubble destruction in treating liver disease.
UltraCon: Harmonic motion imaging tracks breast tumor response to chemo
By Amerigo Allegretto
Harmonic motion imaging can track mechanical property changes of breast tumors in response to neoadjuvant chemotherapy.
April 10, 2024
Yangpei Liu from Columbia University in Ney York City discussed findings at UltraCon suggesting that harmonic motion imaging could be a viable predictor of early treatment response.
UltraCon: Former Medtronic CEO talks ultrasound's future with AuntMinnie.com
By Amerigo Allegretto
Former Medtronic Chairman and CEO Omar Ishrak, PhD, spoke with AuntMinnie.com at UltraCon on the future of ultrasound and market creation.
April 10, 2024
Img 2502
UltraCon: Machine learning predicts sonographer burnout
By Amerigo Allegretto
Machine-learning approaches can predict burnout among sonographers, though established burnout indices may be enough, according to research presented April 9 at UltraCon.
April 9, 2024
Jennifer Bagley from the University of Oklahoma presents findings at UltraCon on the performance of two machine learning approaches in predicting burnout among sonographers.
UltraCon: Ultrasound empowers patients with prosthetic limbs
By Amerigo Allegretto
Gil Weinberg, PhD, a founding director of Georgia Tech's Center for Music Technology, spoke with AuntMinnie.com on ultrasound's use in prosthetics.
April 9, 2024
Img 2547
SRU releases consensus statement on endometriosis detection
By Amerigo Allegretto
The Society of Radiologists in Ultrasound (SRU) has issued a new expert consensus statement that aims to improve endometriosis evaluation.
April 9, 2024
Screenshot (1140)
UltraCon: Microflow imaging on par with CEUS for guiding tumor ablation
By Amerigo Allegretto
Microflow imaging performs just as well as contrast-enhanced ultrasound (CEUS) for guiding tumor ablation and may be an economic alternative.
April 9, 2024
Ziyue Hu, MD, from Sichuan Cancer Hospital in China highlighted findings at UltraCon, showing that along with comparable performance in treating thyroid nodules, microflow imaging is a less costly and invasive approach to tumor ablation than CEUS.
Page 1 of 509
Next Page